Blog

Posted by Michael Wonder on 25 Sep 2015

CADTH drug portfolio information sessions

25 September 2015 - The CADTH Drug Portfolio Information Sessions are an opportunity to receive an update on CADTH’s Drug Portfolio, ...

Posted by Michael Wonder on 15 Sep 2015

CADTH calls for feedback on draft report on drugs for chronic hepatitis C infection

15 September 2015 - CADTH is pleased to invite all interested parties to provide feedback on draft recommendations for the CADTH ...

Posted by Michael Wonder on 04 Sep 2015

CADTH calls for patient input on a new submission from Eli Lilly for Basaglar

4 September 2015 - CADTH has received notice of a pending submission from Eli Lilly for Basaglar (insulin glargine) for use ...